Abstract:Chronic inflammatory musculoskeletal disorders characterized by prolonged muscle inflammation, resulting in enduring pain and diminished functionality, pose significant challenges for the patients. Emerging scientific evidence points to mitochondrial malfunction as a pivotal factor contributing to these ailments. Mitochondria play a critical role in powering skeletal muscle activity, but in the context of persistent inflammation, disruptions in their quantity, configuration, and performance have been well-documented. Various disturbances, encompassing alterations in mitochondrial dynamics (such as fission and fusion), calcium regulation, oxidative stress, biogenesis, and the process of mitophagy, are believed to play a central role in the progression of these disorders. Additionally, unfolded protein responses and the accumulation of fatty acids within muscle cells may adversely affect the internal milieu, impairing the equilibrium of mitochondrial functioning. The structural discrepancies between different mitochondrial subsets namely, intramyofibrillar and subsarcolemmal mitochondria likely impact their metabolic capabilities and susceptibility to inflammatory influences. The release of signals from damaged mitochondria is known to incite inflammatory responses. Intriguingly, migrasomes and extracellular vesicles serve as vehicles for intercellular transfer of mitochondria, aiding in the removal of impaired mitochondria and regulation of inflammation. Viral infections have been implicated in inducing stress on mitochondria. Prolonged dysfunction of these vital organelles sustains oxidative harm, metabolic irregularities, and heightened cytokine release, impeding the body's ability to repair tissues. This review provides a comprehensive analysis of advancements in understanding changes in the intracellular environment, mitochondrial architecture and distribution, biogenesis, dynamics, autophagy, oxidative stress, cytokines associated with mitochondria, vesicular structures, and associated membranes in the context of chronic inflammatory musculoskeletal disorders. Strategies targeting key elements regulating mitochondrial quality exhibit promise in the restoration of mitochondrial function, alleviation of inflammation, and enhancement of overall outcomes.

Role of Mitochondria in Physiology of Chondrocytes and Diseases of Osteoarthritis and Rheumatoid Arthritis

The Role of SIRT3-mediated Mitochondrial Homeostasis in Osteoarthritis

Mitochondria: Potential Targets for Osteoarthritis

The metabolic characteristics and changes of chondrocytes in vivo and in vitro in osteoarthritis

The Role of Mitochondrial Metabolism, AMPK-SIRT Mediated Pathway, LncRNA and MicroRNA in Osteoarthritis

Mitochondrial Role on Cellular Apoptosis, Autophagy, and Senescence during Osteoarthritis Pathogenesis

Epigenetic Regulation of Chondrocytes Affected by Mitochondria Through Mechanotransduction in Osteoarthritis

Mechanisms linking mitochondrial mechanotransduction and chondrocyte biology in the pathogenesis of osteoarthritis

Mitochondrial quality control dysfunction in osteoarthritis: Mechanisms, therapeutic strategies & future prospects

From Dysfunction to Healing: Advances in Mitochondrial Therapy for Osteoarthritis

The role of mitochondrial quality control mechanisms in chondrocyte senescence

Role of Chondrocytes in Cartilage Formation, Progression of Osteoarthritis and Cartilage Regeneration

The Role of Autophagy in Osteoarthritis

Advances in the study of mitophagy in osteoarthritis

Mitochondria in health, disease, and aging

The Role of Autophagy in Osteoarthritic Cartilage

The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis.

The Effect of Mitochondrial Fusion on Chondrogenic Differentiation of Cartilage Progenitor/stem Cells Via Notch2 Signal Pathway

A mitochondrial PCR gene chip based study on the pathogenesis of osteoarthritis

Autophagy and apoptosis: regulatory factors of chondrocyte phenotype transition in osteoarthritis

Mitochondrial mechanisms in the pathogenesis of chronic inflammatory musculoskeletal disorders